Evaluation of BTX 1503 in Patients With Moderate to Severe Acne Vulgaris

PHASE2CompletedINTERVENTIONAL
Enrollment

368

Participants

Timeline

Start Date

June 26, 2018

Primary Completion Date

August 16, 2019

Study Completion Date

September 5, 2019

Conditions
Acne Vulgaris
Interventions
DRUG

BTX 1503

BTX 1503 Dose 1 liquid formulation, or BTX 1503 Dose 2 liquid formulation

DRUG

Vehicle

Placebo

Trial Locations (36)

2217

St George Dermatology & Skim Cancer Center, Kogarah

2606

Woden Dermatology, Phillip

3002

Sinclair Dermatology, East Melbourne

4102

Varacity Clinical Research, Woolloongabba

4217

The Skin Centre, Benowa

5000

Cmax Clinical Research, Adelaide

5073

North Eastern Health Specialist, Hectorville

6009

Captain Sterline Medical Centre, Nedlands

6100

Burswood Dermatology, Burwood

6160

Fremantle Dermatology, Fremantle

17033

Penn State Hershey Medical, Hershey

29464

Coastal Carolina Research Center, Mt. Pleasant

29607

Greenville Dermatology, LLC, Greenville

33143

Well Phrama Medical Research, Miami

33162

Tory Sullivan, M.D., PA, North Miami Beach

33351

Precision Clinical Research, Sunrise

40241

DS Research - Louisville, Louisville

43016

Aventiv Research, Dublin

55432

Minnesota Clinical Study Center, Fridley

63141

Washington University School of Medicine - Dermatology, St Louis

64506

Medisearch Clinical Trials, Saint Joseph

70115

Delricht Research, New Orleans

72212

Applied Research Center of Arkansas, Little Rock

77056

Suzanne Bruce and Associates, PA, Houston

77845

J&S Studies, Inc., College Station

78704

Avant Research Associates, LLC, Austin

78759

DermReasearch, Austin

89148

JDR Dermatology Research, Las Vegas

90404

Clinical Science Insitute, Santa Monica

91324

Quest Dermatology Research, Northridge

91436

Encino Research Center, Encino

92562

Dermatology Specialist, Inc., Murrieta

02135

Metro Boston Clinical, Brighton

07960

The Acne Treatment and Research Center, Morristown

02919

Clinical Partners, LLC, Johnston

053

Skin & Canver Foundation Inc., Carlton

Sponsors
All Listed Sponsors
lead

Botanix Pharmaceuticals

INDUSTRY